Ed Susman
Anticoagulant Use Among Afib Patients Wanes Over Time
Anticoagulant Use Among Afib Patients Wanes Over Time
ORLANDO -- Barely half of patients with atrial fibrillation who were prescribed rivaroxaban (Xarelto) to prevent stroke remained on the treatment after 2 years, but their adherence was still better than Afib patients on warfarin or dabigatran (Pradaxa), researchers said here.
ECCO: Circulating Tumor Cells May Aid in Breast Cancer Prognosis
BARCELONA -- Monitoring circulating tumor cells in women with breast cancer may be help guide treatment and refine prognoses, according to preliminary data from German investigators.
DOD PROSTATE: Prostate Cancer Patients Should Heed Cardiovascular Risk Factors
ATLANTA -- A prostate cancer diagnosis should be a cardiovascular wake-up call, said researchers here.
APSS: New drugs for insomnia will focus on safety
MINNEAPOLIS, Minn. -- Sleep specialists here reviewed the problems and alternatives for treating insomnia.
APSS: Short-Wave Sleep Enhancers May Have Roll in Insomnia
MINNEAPOLIS, Minn. -- Despite disappointing performance in clinical trials, anti-insomnia drugs that improve short-wave sleep may still have a role in helping people get a good night's rest, a specialist predicted here.
ACC: Early Aggressive Management Urged to Prevent Cardiovascular Risk Migration
NEW ORLEANS -- Cardiovascular risk is not static and intermediate risk patients may be on their way toward high risk, although that migration might be avoided or slowed by aggressive management.
ASCO PROSTATE: Imaging Not Helpful in Men With Low PSA in Biochemical Failure
KISSIMMEE, Fla. -- After definitive prostate cancer therapy, there is little value in imaging studies when patients with biochemical failure are asymptomatic and have PSA levels less than 5 ng/mL, researchers here reported.
ASCO PROSTATE: Survival After Radiation Plus Androgen Mirrors Healthy Men
KISSIMMEE, Fla. -- Radiation and androgen deprivation appears to bestow survival times for prostate cancer patients that are similar to the life expectancies of men of the same age who did not have cancer, researchers here reported.
ASCO PROSTATE: Docetaxel-Based Therapy Viewed for Refractory Prostate Cancer
KISSIMMEE, Fla. -- Docetaxel (Taxotere)-based combination therapy using is being investigated in a dozen trials for hormone refractory prostate cancer, investigators reported here.
ASCO PROSTATE: Potency Drugs Improve Sexual Function After Prostate Cancer Therapy
KISSIMMEE, Fla. -- Prostate cancer patients taking sildenafil (Viagra) or its ilk reported improved sexual functioning and interest following radiation therapy and radical prostatectomy, researchers here reported.